Smith Group Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-160	Closed	-$4K	–	273
2021 Q4	$4K	Hold	160	–	–	﹤0.01%	346
2021 Q3	$3K	Buy	+160	New	+$3.08K	﹤0.01%	359
2020 Q3	–	Sell	-3,720	Closed	-$180K	–	307
2020 Q2	$180K	Sell	3,720 -60	-2%	-$2.88K	0.01%	168
2020 Q1	$160K	Sell	3,780 -10	-0.3%	-$412	0.01%	182
2019 Q4	$162K	Sell	3,790 -300	-7%	-$13.1K	0.01%	214
2019 Q3	$147K	Buy	4,090 +1,250	+44%	+$37.9K	0.01%	211
2019 Q2	$76K	Hold	2,840	–	–	﹤0.01%	253
2019 Q1	$76K	Sell	2,840 -8,800	-76%	-$206K	﹤0.01%	275
2018 Q4	$188K	Buy	+11,640	New	+$226K	0.01%	246
2016 Q2	–	Sell	-16,720	Closed	-$467K	–	471
2016 Q1	$467K	Sell	16,720 -150	-0.9%	-$3.27K	0.01%	172
2015 Q4	$601K	Buy	+16,870	New	+$594K	0.02%	198